Cargando…

Γδ T Cell-Based Immunotherapy in Melanoma: State of the Art

Metastatic melanoma is still associated with a poor prognosis, and there is increasing interest in immunotherapy alone or in combination with other adjuvant therapies. Γδ T lymphocytes play a pivot role in the immune response against cancer, but while γδ-based immunotherapy is already a clinical rea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toia, F., Di Stefano, A. B., Meraviglia, S., Lo Presti, E., Pirrello, R., Rinaldi, G., Fulfaro, F., Dieli, F., Cordova, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556315/ https://www.ncbi.nlm.nih.gov/pubmed/31239842 http://dx.doi.org/10.1155/2019/9014607

Ejemplares similares

Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017)

Lymphopenia in COVID-19: γδ T Cells-Based Therapeutic Opportunities
por: Lo Presti, Elena, et al.
Publicado: (2021)

Tumor-Infiltrating γδ T Lymphocytes: Pathogenic Role, Clinical Significance, and Differential Programing in the Tumor Microenvironment
por: Lo Presti, Elena, et al.
Publicado: (2014)

γδ T cells and their clinical application in colon cancer
por: Corsale, Anna Maria, et al.
Publicado: (2023)

Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
por: Cordova, Adriana, et al.
Publicado: (2012)

Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?
por: Corsale, Anna Maria, et al.
Publicado: (2021)

Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
por: Todaro, Matilde, et al.
Publicado: (2013)

γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
por: Lo Presti, Elena, et al.
Publicado: (2018)

Phenotypical and Functional Alteration of γδ T Lymphocytes in COVID-19 Patients: Reversal by Statins
por: Di Simone, Marta, et al.
Publicado: (2022)

Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes
por: Dieli, Francesco, et al.
Publicado: (2013)

Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome
por: Toia, Francesca, et al.
Publicado: (2016)

γδ T Cells Cross-Link Innate and Adaptive Immunity in Mycobacterium tuberculosis Infection
por: Meraviglia, Serena, et al.
Publicado: (2011)

3D models for melanoma γδ T cell‐based immunotherapy
por: Huber, Veronica, et al.
Publicado: (2022)

Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells
por: Presti, Elena Lo, et al.
Publicado: (2016)

The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
por: Legut, Mateusz, et al.
Publicado: (2015)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

γδ T Cells and Their Potential for Immunotherapy
por: Wu, Yan-Ling, et al.
Publicado: (2014)

γδ T cells in cancer immunotherapy
por: Zou, Chang, et al.
Publicado: (2016)

Immunotherapy of acute myeloid leukemia based on γδ T cells
por: Gertner-Dardenne, Julie, et al.
Publicado: (2012)

Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy
por: Khan, Mohd Wajid A., et al.
Publicado: (2014)

γδ T Cell Immunotherapy—A Review
por: Kobayashi, Hirohito, et al.
Publicado: (2015)

Propeller Flaps: A Review of Indications, Technique, and Results
por: D'Arpa, Salvatore, et al.
Publicado: (2014)

Animal models of vascularized nerve grafts: a systematic review
por: Toia, Francesca, et al.
Publicado: (2022)

γδ T Lymphocytes as a Double-Edged Sword—State of the Art in Gynecological Diseases
por: Pawłowska, Anna, et al.
Publicado: (2022)

Editorial: Next generation γδ T cell-based tumor immunotherapy
por: Tan, Andy Hee-Meng, et al.
Publicado: (2022)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
por: de Vries, Natasja L., et al.
Publicado: (2023)

γδ T Cells: The Ideal Tool for Cancer Immunotherapy
por: Yazdanifar, Mahboubeh, et al.
Publicado: (2020)

3D modelling of γδ T‐cell immunotherapy
por: Hull, Caroline M., et al.
Publicado: (2022)

The emerging role of γδ T cells in cancer immunotherapy
por: Nussbaumer, Oliver, et al.
Publicado: (2019)

γδ T cells in immunotherapies for B-cell malignancies
por: Rimailho, Léa, et al.
Publicado: (2023)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
por: Song, Yuan, et al.
Publicado: (2022)

Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy
por: Burnham, Rebecca E., et al.
Publicado: (2020)

Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
por: Barros, Mateus de Souza, et al.
Publicado: (2021)

A close look at current γδ T-cell immunotherapy
por: Ma, Ling, et al.
Publicado: (2023)

Biological characteristics of γδT cells and application in tumor immunotherapy
por: Zhu, Renhong, et al.
Publicado: (2023)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023)

Possibility of γδ T cell immunotherapy for HTLV-1-infected individuals
por: Sato, Tomoo, et al.
Publicado: (2011)

Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ns5i3dnd4ssg3sn3ul1u9q88l8